CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Goserelin
Accession: CHEBI:5523
browse the term
Synonyms: related_synonym: Decapeptide I; Formula=C59H84N18O14; Goserelin acetate; InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1; InChIKey=BLCLNMBMMGCOAS-URPVMXJPSA-N; SMILES=C([C@H](NC([C@H](CC1=CNC=N1)NC(=O)[C@@H]2CCC(N2)=O)=O)C(N[C@H](C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](C(N[C@H](C(N[C@H](C(=O)N4[C@H](C(NNC(N)=O)=O)CCC4)CCCNC(=N)N)=O)CC(C)C)=O)COC(C)(C)C)=O)=O)CO)=O)C=5C6=C(NC5)C=CC=C6; zoladex
xref: CAS:65807-02-5; Drug_Central:1327; HMDB:HMDB0014259; KEGG:D00573
xref_mesh: MESH:D017273
G
Ar
androgen receptor
multiple interactions
ISO
[Goserelin co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride] results in decreased expression of AR protein
CTD
PMID:24323034
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bcl2
BCL2, apoptosis regulator
increases expression
ISO
Goserelin results in increased expression of BCL2 protein
CTD
PMID:16973256
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bglap
bone gamma-carboxyglutamate protein
multiple interactions
ISO
[Goserelin co-treated with kuntai capsule] affects the expression of BGLAP protein
CTD
PMID:25566615
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Esr1
estrogen receptor 1
decreases expression
ISO
Goserelin results in decreased expression of ESR1 protein
CTD
PMID:16973256
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions decreases expression
ISO
[Goserelin co-treated with kuntai capsule] results in decreased expression of FSHB protein Goserelin results in decreased expression of FSHB protein
CTD
PMID:25566615
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Pgr
progesterone receptor
decreases expression
ISO
Goserelin results in decreased expression of PGR protein
CTD
PMID:16973256
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Tp53
tumor protein p53
decreases expression
ISO
Goserelin results in decreased expression of TP53 protein
CTD
PMID:16973256
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all